Annelise E Barron Selected Research

Peptoids

11/2022	Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens.
1/2022	Efficacy of Cathelicidin-Mimetic Antimicrobial Peptoids against Staphylococcus aureus.
3/2021	Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids.
1/2018	Effect of side chain hydrophobicity and cationic charge on antimicrobial activity and cytotoxicity of helical peptoids.
1/2018	Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins.
1/2016	In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents.
7/2015	Prostate tumor specific peptide-peptoid hybrid prodrugs.
1/2014	Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity.
6/2011	Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis.
6/2011	Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annelise E Barron Research Topics

Disease

11	Infections 11/2022 - 02/2011
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2019 - 01/2005
4	Neoplasms (Cancer) 07/2015 - 07/2005
2	Wounds and Injuries (Trauma) 01/2022 - 10/2010
2	Amyloid Plaque 01/2021 - 01/2020
2	Newborn Respiratory Distress Syndrome 10/2008 - 11/2003
1	COVID-19 01/2022
1	Inflammation (Inflammations) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hypoxia (Hypoxemia) 01/2018
1	Hemolysis 01/2018
1	Acute Lung Injury 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 07/2015
1	Neuroblastoma 03/2015
1	Neuroinflammatory Diseases 03/2015
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Obesity 04/2012
1	Cystic Fibrosis (Mucoviscidosis) 06/2011
1	Tuberculosis (Tuberculoses) 06/2011
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2011
1	Foreign Bodies (Foreign Body) 01/2011

Drug/Important Bio-Agent (IBA)

12	PeptoidsIBA 11/2022 - 11/2003
6	Surface-Active Agents (Surfactants)IBA 06/2019 - 11/2003
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2003
3	CathelicidinsIBA 01/2022 - 03/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2011
3	Peptides (Polypeptides)IBA 01/2020 - 07/2015
2	CytokinesIBA 01/2022 - 03/2015
2	Antiviral Agents (Antivirals)IBA 03/2021 - 02/2011
2	Protein CIBA 06/2019 - 11/2003
1	Pharmaceutical PreparationsIBA 11/2022
1	Antimicrobial PeptidesIBA 11/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Methicillin (Metin)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Lipid NanoparticlesIBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Islet Amyloid PolypeptideIBA 01/2020
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2018
1	ProdrugsIBA 07/2015
1	Antimicrobial Cationic PeptidesIBA 07/2015
1	ChemokinesIBA 03/2015
1	Interleukin-8 (Interleukin 8)IBA 03/2015
1	Peptide Hydrolases (Proteases)FDA Link 01/2014
1	AdiponectinIBA 04/2012
1	GelsIBA 01/2011
1	PolymersIBA 01/2011
1	HydrogelsIBA 01/2011
1	Contrast MediaIBA 01/2011
1	Anti-Infective Agents (Microbicides)IBA 01/2011
1	Insulin (Novolin)FDA Link 10/2010
1	IonsIBA 07/2005
1	MetalsIBA 07/2005

Therapy/Procedure

6	Therapeutics 06/2019 - 11/2003
1	Arthroplasty 01/2018
1	Heterologous Transplantation (Xenotransplantation) 01/2014
1	Microspheres (Microsphere) 10/2010